Prevention of intracerebral hemorrhage recurrence

CONTINUUM Lifelong Learning in Neurology

Volumn 17, Issue 6, 2011, Pages 1304-1317

  Kase, Carlos S ^a   Kurth, Tobias ^a  

^a BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ALCOHOL; ALPHA TOCOPHEROL; ANTITHROMBOCYTIC AGENT; APIXABAN; ATORVASTATIN; DABIGATRAN; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; WARFARIN;

ALCOHOL CONSUMPTION; ANTICOAGULANT THERAPY; BRAIN HEMORRHAGE; CIGARETTE SMOKING; CORONARY ARTERY DISEASE; DIABETES MELLITUS; DISEASE ASSOCIATION; DRUG MEGADOSE; GENETIC POLYMORPHISM; GENETIC SUSCEPTIBILITY; HEART ATRIUM FIBRILLATION; HEART INFARCTION; HUMAN; HYPERTENSION; LONG TERM CARE; MIGRAINE WITH AURA; NEUROPROTECTION; PATHOPHYSIOLOGY; PRIMARY PREVENTION; PROSPECTIVE STUDY; RECURRENT DISEASE; REVIEW; RISK FACTOR; SECONDARY PREVENTION; SMOKING CESSATION; STROKE;

EID: 84856102618     PISSN: 10802371     EISSN: 15386899     Source Type: Journal    
DOI: 10.1212/01.CON.0000410037.64971.e3     Document Type: Review

References (57)

1. Broderick J, Connolly S, Feldmann E, et al. Guidelines for the management of spontaneous intracerebral hemorrhage in adults: 2007 update: a guideline from the American Heart Association/American Stroke Association Stroke Council, High Blood Pressure Research Council, and the Quality of Care and Outcomes in Research Interdisciplinary Working Group. Stroke 2007; 38(6): 2001-2023. (Pubitemid 46850654)
2. Fogelholm R, Murros K, Rissanen A, Avikainen S. Long term survival after primary intracerebral haemorrhage: a retrospective population based study. J Neurol Neurosurg Psychiatry 2005; 76(11): 1534-1538. (Pubitemid 41531701)
3. Lee KS, Bae HG, Yun IG. Recurrent intracerebral hemorrhage due to hypertension. Neurosurgery 1990; 26(4): 586-590. (Pubitemid 20120705)
4. Fogelholm R, Nuutila M, Vuorela AL. Primary intracerebral haemorrhage in the Jyvä skylä region, central Finland, 1985-89: incidence, case fatality rate, and functional outcome. J Neurol Neurosurg Psychiatry 1992; 55(7): 546-552.
5. Chen ST, Chiang CY, Hsu CY, et al. Recurrent hypertensive intracerebral hemorrhage. Acta Neurol Scand 1995; 91(2): 128-132.
6. Misra UK, Kalita J. Case reports: recurrent hypertensive intracerebral hemorrhage. Am J Med Sci 1995; 310(4): 156-157.
7. Passero S, Burgalassi L, D'Andrea P, Battistini N. Recurrence of bleeding in patients with primary intracerebral hemorrhage. Stroke 1995; 26(7): 1189-1192.
8. Maruishi M, Shima T, Okada Y, et al. Clinical findings in patients with recurrent intracerebral hemorrhage. Surg Neurol 1995; 44(5): 444-449.
9. Neau JP, Ingrand P, Couderq C, et al. Recurrent intracerebral hemorrhage. Neurology 1997; 49(1): 106-113. (Pubitemid 27328689)
10. González-Duarte A, Cantú C, Ruíz-Sandoval JL, Barinagarrementeria F. Recurrent primary cerebral hemorrhage: frequency, mechanisms, and prognosis. Stroke 1998; 29(9): 1802-1805. (Pubitemid 28399967)
11. Hankey GJ, Jamrozik K, Broadhurst RJ, et al. Long-term risk of first recurrent stroke in the Perth Community Stroke Study. Stroke 1998; 29(12): 2491-2500. (Pubitemid 28543996)
12. Arakawa S, Saku Y, Ibayashi S, et al. Blood pressure control and recurrence of hypertensive brain hemorrhage. Stroke 1998; 29(9): 1806-1809. (Pubitemid 28399968)
13. Bae H, Jeong D, Doh J, et al. Recurrence of bleeding in patients with hypertensive intracerebral hemorrhage. Cerebrovasc Dis 1999; 9(2): 102-108. (Pubitemid 29084225)
14. Hill MD, Silver FL, Austin PC, Tu JV. Rate of stroke recurrence in patients with primary intracerebral hemorrhage. Stroke 2000; 31(1): 123-127. (Pubitemid 30035763)
15. Vermeer SE, Algra A, Franke CL, et al. Long-term prognosis after recovery from primary intracerebral hemorrhage. Neurology 2002; 59(2): 205-209. (Pubitemid 34779178)
16. Buhl R, Barth H, Mehdorn HM. Risk of recurrent intracerebral hemorrhages. Neurol Res 2003; 25(8): 853-856. (Pubitemid 37499721)
17. Inagawa T. Recurrent primary intracerebral hemorrhage in Izumo City, Japan. Surg Neurol 2005; 64(1): 28-35. (Pubitemid 40916958)
18. Hanger HC, Wilkinson TJ, Fayez-Iskander N, Sainsbury R. The risk of recurrent stroke after intracerebral haemorrhage. J Neurol Neurosurg Psychiatry 2007; 78(8): 836-840. (Pubitemid 47204588)
19. Azarpazhooh MR, Nicol MB, Donnan GA, et al. Patterns of stroke recurrence according to subtype of first stroke event: the North East Melbourne Stroke Incidence Study (NEMESIS). Int J Stroke 2008; 3(3): 158-164.
20. Zia E, Engström G, Svensson PJ, et al. Three-year survival and stroke recurrence rates in patients with primary intracerebral hemorrhage. Stroke 2009; 40(11): 3567-3573.
21. Biffi A, Halpin A, Towfighi A, et al. Aspirin and recurrent intracerebral hemorrhage in cerebral amyloid angiopathy. Neurology 2010; 75(8): 693-698.
22. Westover MB, Bianchi MT, Eckman MH, Greenberg SM. Statin use following intracerebral hemorrhage: a decision analysis. Arch Neurol 2011; 68(5): 573-579.
23. Feldmann E, Broderick JP, Kernan WN, et al. Major risk factors for intracerebral hemorrhage in the young are modifiable. Stroke 2005; 36(9): 1881-1885. (Pubitemid 41266519)
24. Woo D, Haverbusch M, Sekar P, et al. Effect of untreated hypertension on hemorrhagic stroke. Stroke 2004; 35(7): 1703-1708. (Pubitemid 38823651)
25. Thrift AG, McNeil JJ, Forbes A, Donnan GA. Three important subgroups of hypertensive persons at greater risk of intracerebral hemorrhage: Melbourne Risk Factor Study Group. Hypertension 1998; 31(6): 1223-1229. (Pubitemid 28248819)
26. Chapman N, Huxley R, Anderson C, et al. Effects of a perindopril-based blood pressure-lowering regimen on the risk of recurrent stroke according to stroke subtype and medical history: the PROGRESS Trial. Stroke 2004; 35(1): 116-121. (Pubitemid 38057603)
27. O'Donnell MJ, Xavier D, Liu L, et al. Risk factors for ischaemic and intracerebral haemorrhagic stroke in 22 countries (the INTERSTROKE study): a case-control study. Lancet 2010; 376(9735): 112-123.
28. Lee SH, Kim BJ, Bae HJ, et al. Effects of glucose level on early and long-term mortality after intracerebral haemorrhage: the Acute Brain Bleeding Analysis Study. Diabetologia 2010; 53(3): 429-434.
29. Tetri S, Juvela S, Saloheimo P, et al. Hypertension and diabetes as predictors of early death after spontaneous intracerebral hemorrhage. J Neurosurg 2009; 110(3): 411-417.
30. Bruno A, Levine SR, Frankel MR, et al. Admission glucose level and clinical outcomes in the NINDS rt-PA Stroke Trial. Neurology 2002; 59(5): 669-674.
31. Berger K, Ajani UA, Kase CS, et al. Light-to-moderate alcohol consumption and risk of stroke among U.S. male physicians. N Engl J Med 1999; 341(21): 1557-1564.
32. Thrift AG, Donnan GA, McNeil JJ. Heavy drinking, but not moderate or intermediate drinking, increases the risk of intracerebral hemorrhage. Epidemiology 1999; 10(3): 307-312. (Pubitemid 29187768)
33. Iso H, Baba S, Mannami T, et al. Alcohol consumption and risk of stroke among middle-aged men: the JPHC Study Cohort I. Stroke 2004; 35(5): 1124-1129. (Pubitemid 38543530)
34. Andersen KK, Olsen TS, Dehlendorff C, Kammersgaard LP. Hemorrhagic and ischemic strokes compared: stroke severity, mortality, and risk factors. Stroke 2009; 40(6): 2068-2072.
35. Kurth T, Kase CS, Berger K, et al. Smoking and the risk of hemorrhagic stroke in men. Stroke 2003; 34(5): 1151-1155. (Pubitemid 36547505)
36. Kurth T, Kase CS, Berger K, et al. Smoking and risk of hemorrhagic stroke in women. Stroke 2003; 34(12): 2792-2795. (Pubitemid 37517743)
37. Schürks M, Rist PM, Bigal ME, et al. Migraine and cardiovascular disease: systematic review and meta-analysis. BMJ 2009; 339: b3914.
38. Kurth T, Kase CS, Schürks M, et al. Migraine and risk of haemorrhagic stroke in women: prospective cohort study. BMJ 2010; 341: c3659.
39. Eckman MH, Rosand J, Knudsen KA, et al. Can patients be anticoagulated after intracerebral hemorrhage? A decision analysis. Stroke 2003; 34(7): 1710-1716. (Pubitemid 36842632)
40. Connolly SJ, Ezekowitz MD, Yusuf S, et al. Dabigatran versus warfarin in patients with atrial fibrillation [erratum appears in N Engl J Med 2010; 363(19): 1877]. N Engl J Med 2009; 361(12): 1139-1151.
41. Connolly SJ, Eikelboom J, Joyner C, et al; AVERROES Steering Committee and Investigators. Apixaban in patients with atrial fibrillation. N Engl J Med 2011; 364(9): 806-817.
42. Majeed A, Kim YK, Roberts RS, et al. Optimal timing of resumption of warfarin after intracranial hemorrhage. Stroke 2010; 41(12): 2860-2866.
43. Viswanathan A, Rakich SM, Engel C, et al. Antiplatelet use after intracerebral hemorrhage. Neurology 2006; 66(2): 206-209. (Pubitemid 43970155)
44. Alberts MJ. Do antiplatelet agents increase the risk of recurrent intracerebral hemorrhage? Nat Clin Pract Neurol 2006; 2(9): 480-481. (Pubitemid 44275723)
45. Flynn RW, MacDonald TM, Murray GD, et al. Prescribing antiplatelet medicine and subsequent events after intracerebral hemorrhage. Stroke 2010; 41(11): 2606-2611.
46. Stroke Prevention by Aggressive Reduction in Cholesterol Levels (SPARCL) Investigators. High-dose atorvastatin after stroke or transient ischemic attack. N Engl J Med 2006; 355(6): 549-559.
47. Heart Protection Study Collaborative Group; Collins R, Armitage J, Parish S, et al. Effects of cholesterol-lowering with simvastatin on stroke and other major vascular events in 20536 people with cerebrovascular disease or other high-risk conditions. Lancet 2004; 363(9411): 757-767.
48. Goldstein LB, Amarenco P, Szarek M, et al. Hemorrhagic stroke in the Stroke Prevention by Aggressive Reduction in Cholesterol Levels study. Neurology 2008; 70(24 pt 2): 2364-2370.
49. Goldstein LB. Statins after intracerebral hemorrhage: to treat or not to treat. Arch Neurol 2011; 68(5): 565-566.
50. Vivekananthan DP, Penn MS, Sapp SK, et al. Use of antioxidant vitamins for the prevention of cardiovascular disease: meta-analysis of randomised trials. Lancet 2003; 361(9374): 2017-2023. (Pubitemid 36695043)
51. Eidelman RS, Hollar D, Hebert PR, et al. Randomized trials of vitamin E in the treatment and prevention of cardiovascular disease. Arch Intern Med 2004; 164(14): 1552-1556. (Pubitemid 38970477)
52. Sesso HD, Buring JE, Christen WG, et al. Vitamins E and C in the prevention of cardiovascular disease in men: the Physicians' Health Study II randomized controlled trial. JAMA 2008; 300(18): 2123-2133.
53. Schürks M, Glynn RJ, Rist PM, et al. Effects of vitamin E on stroke subtypes: meta-analysis of randomised controlled trials. BMJ 2010; 341: c5702.
54. Yusuf S, Dagenais G, Pogue J, et al. Vitamin E supplementation and cardiovascular events in high-risk patients. The Heart Outcomes Prevention Evaluation Study Investigators. N Engl J Med 2000; 342(3): 154-160. (Pubitemid 30051646)
55. Leppälä JM, Virtamo J, Fogelholm R, et al. Controlled trial of alpha-tocopherol and beta-carotene supplements on stroke incidence and mortality in male smokers. Arterioscler Thromb Vasc Biol 2000; 20(1): 230-235. (Pubitemid 30048369)
56. Lee IM, Cook NR, Gaziano JM, et al. Vitamin E in the primary prevention of cardiovascular disease and cancer: the Women's Health Study: a randomized controlled trial. JAMA 2005; 294(1): 56-65. (Pubitemid 41002839)
57. Cook NR, Albert CM, Gaziano JM, et al. A randomized factorial trial of vitamins C and E and beta carotene in the secondary prevention of cardiovascular events in women: results from the Women's Antioxidant Cardiovascular Study. Arch Intern Med 2007; 167(15): 1610-1618. (Pubitemid 47280341)